-
Mashup Score: 0KDIGO Discusses the Need for CKD Prevention, the Complexity of Maintaining Kidney Health - 13 hour(s) ago
Most individuals with chronic kidney disease (CKD) are unaware of their disease, according to a KDIGO controversies conference on CKD prevention.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 0Rituximab Linked With Renal Response in Refractory Lupus Nephritis - 16 hour(s) ago
Rituximab may offer therapeutic value in lupus nephritis unresponsive to standard regimens.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Rituximab, a monoclonal antibody that targets the CD20 antigen on B-lymphocytes, may offer therapeutic value in lupus nephritis unresponsive to standard regimens. https://t.co/e7SKEg4AQ9 #lupus
-
-
Mashup Score: 0Clinical Quiz: A Young Woman With Acute Kidney Injury, Lupus Nephritis - Renal and Urology News - 2 day(s) ago
Left: Light microscopy | Right: Immunofluorescence microscopy A 24-year-old Hispanic female who is previously healthy presented to the hospital with
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
A 24-year-old Hispanic female who is previously healthy presented to the hospital with fatigue, diffuse joint pain, and leg swelling for the last 6 months that worsened in the last 2 weeks. Answer our latest clinical quiz: https://t.co/6CN3389PTh
-
-
Mashup Score: 0Lower-Dose Abiraterone Is as Efficacious as the Standard Dose for mCRPC - Renal and Urology News - 2 day(s) ago
Standard-dose abiraterone for mCRPC is costly, more toxic, and requires fasting, so a trial tested whether a lower dosage would suffice.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Lower-dose abiraterone demonstrated comparable efficacy to standard-dose abiraterone in select men with mCRPC. https://t.co/zLtjIvb2Md #ASCO25
-
-
Mashup Score: 0Monogenic Lupus Nephritis Signals Earlier Onset and Worse Renal Outcomes - Renal and Urology News - 19 day(s) ago
A team studied the differences between monogenic and nonmonogenic lupus nephritis and the predictors of end-stage kidney disease.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Early genetic screening can help identify monogenic lupus nephritis and anticipate trajectory of disease. https://t.co/93CmmDK3Sd #ERA25
-
-
Mashup Score: 0Renal Hyperfiltration Trajectory Tied With Risk of ESKD, Cardiovascular Events, and Death - Renal and Urology News - 19 day(s) ago
Investigators studied whether changes in renal hyperfiltration status affects patient outcomes using a Korean population cohort of more than 4.5 million patients.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Whether renal hyperfiltration persists or disappears, patients who experience it appear to be at increased risks of kidney failure, cardiovascular events, and all-cause mortality. https://t.co/QzdWQEevjW #ERA25
-
-
Mashup Score: 0Spironolactone Does Not Lower CV Mortality, HF Hospitalization Risk in Patients on Dialysis - Renal and Urology News - 21 day(s) ago
Although spironolactone is very effective in patients that do not require dialysis, investigators tested whether spironolactone is effective in patients on dialysis in a phase 3 trial.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Spironolactone did not lower cardiovascular risks in patients undergoing maintenance dialysis in the phase 3 ACHIEVE trial. https://t.co/ilxBbB1csm #ERA25
-
-
Mashup Score: 0Acellular Tissue Engineered Vessel Maintains Hemodialysis Patency Better Than AVF in High-Risk Patients - 22 day(s) ago
Investigators successfully tested an acellular tissue engineered vessel for hemodialysis vascular access in patients at high-risk for arteriovenous fistula (AVF) maturation failure.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
In a trial, an acellular tissue engineered vessel had superior functional patency for hemodialysis with acceptable safety compared with an arteriovenous fistula in high-risk patients. https://t.co/LTghFltcTP #dialysis
-
-
Mashup Score: 1Inhibiting Factor XI Does Not Decrease Arteriovenous Graft Thrombosis Rate in Hemodialysis - Renal and Urology News - 22 day(s) ago
Investigators evaluated the efficacy and safety of different doses of MK-2060, a monoclonal antibody against Factor XI, to prevent vascular access clotting in patients receiving hemodialysis via an arteriovenous graft (AVG).
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
A phase 2 trial of patients receiving hemodialysis via an arteriovenous graft found no benefit from a factor XI inhibitor. https://t.co/T5ytIoC8Fx #ERA25
-
-
Mashup Score: 0Survival Advantage From Kidney Transplantation vs Dialysis Varies Among Patients - Renal and Urology News - 25 day(s) ago
Study is based on registry data from over 64,000 patients with kidney failure across Europe.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
Study findings can help clinicians and patients with kidney failure make informed decisions about considering kidney transplantation. https://t.co/jEGwqODDmK #ERA25
-
Residual risk for CKD persists despite healthy lifestyles and treatment of risk factors, according to a KDIGO controversies conference report. https://t.co/8xEIclUExx #kidneydisease